Thrivent Financial for Lutherans’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$731K Sell
20,671
-609
-3% -$24.8K ﹤0.01% 2057
2025
Q4
$864K Sell
21,280
-1,052
-5% -$45.8K ﹤0.01% 2009
2025
Q3
$1.05M Sell
22,332
-419
-2% -$21.7K ﹤0.01% 1753
2025
Q2
$1.19M Buy
22,751
+61
+0.3% +$3.35K ﹤0.01% 1680
2025
Q1
$1.37M Sell
22,690
-1,187
-5% -$76.5K ﹤0.01% 1499
2024
Q4
$1.63M Sell
23,877
-310
-1% -$21.6K ﹤0.01% 1592
2024
Q3
$1.74M Sell
24,187
-1,382
-5% -$97.5K ﹤0.01% 1540
2024
Q2
$1.77M Sell
25,569
-1,109
-4% -$80.9K ﹤0.01% 1461
2024
Q1
$2.14M Sell
26,678
-724
-3% -$64.5K ﹤0.01% 1364
2023
Q4
$3M Sell
27,402
-719
-3% -$74.3K 0.01% 1099
2023
Q3
$2.84M Sell
28,121
-1,678
-6% -$193K 0.01% 1062
2023
Q2
$4.05M Sell
29,799
-1,001
-3% -$122K 0.01% 933
2023
Q1
$3.2M Sell
30,800
-1,059
-3% -$102K 0.01% 1005
2022
Q4
$2.82M Sell
31,859
-226
-0.7% -$18.8K 0.01% 1044
2022
Q3
$2.57M Buy
32,085
+3,076
+11% +$290K 0.01% 1080
2022
Q2
$2.78M Buy
29,009
+5,200
+22% +$624K 0.01% 1053
2022
Q1
$3.54M Buy
23,809
+7
+0% +$977 0.01% 1013
2021
Q4
$3.37M Buy
23,802
+229
+1% +$32.4K 0.01% 1072
2021
Q3
$3.08M Sell
23,573
-210
-0.9% -$27.5K 0.01% 1092
2021
Q2
$3.27M Buy
23,783
+7
+0% +$958 0.01% 1128
2021
Q1
$3.1M Buy
23,776
+101
+0.4% +$12.2K 0.01% 1137
2020
Q4
$2.65M Sell
23,675
-16
-0.1% -$1.51K 0.01% 1148
2020
Q3
$1.86M Sell
23,691
-194
-0.8% -$15.8K 0.01% 1196
2020
Q2
$1.72M Buy
23,885
+101
+0.4% +$7.03K 0.01% 1152
2020
Q1
$1.36M Buy
23,784
+1,187
+5% +$109K ﹤0.01% 1133
2019
Q4
$2.53M Buy
22,597
+117
+0.5% +$12.5K 0.01% 928
2019
Q3
$2.16M Buy
22,480
+2,162
+11% +$203K 0.01% 954
2019
Q2
$1.74M Buy
20,318
+550
+3% +$45.2K 0.01% 1084
2019
Q1
$1.64M Buy
19,768
+1,566
+9% +$114K 0.01% 1068
2018
Q4
$1.17M Buy
18,202
+729
+4% +$49.9K ﹤0.01% 1069
2018
Q3
$1.38M Buy
17,473
+352
+2% +$27.2K ﹤0.01% 1086
2018
Q2
$1.25M Sell
17,121
-1,877
-10% -$128K ﹤0.01% 1122
2018
Q1
$1.2M Sell
18,998
-46,991
-71% -$2.81M ﹤0.01% 1128
2017
Q4
$3.36M Buy
65,989
+359
+0.5% +$18.7K 0.01% 746
2017
Q3
$3.44M Buy
65,630
+160
+0.2% +$8.03K 0.01% 716
2017
Q2
$3.33M Buy
65,470
+1,600
+3% +$79.2K 0.01% 690
2017
Q1
$2.84M Buy
63,870
+700
+1% +$30.1K 0.01% 729
2016
Q4
$2.79M Buy
63,170
+800
+1% +$34K 0.01% 751
2016
Q3
$2.5M Sell
62,370
-210
-0.3% -$8.92K 0.01% 799
2016
Q2
$2.99M Buy
62,580
+9,980
+19% +$423K 0.01% 748
2016
Q1
$2.21M Buy
52,600
+780
+2% +$30.6K 0.01% 834
2015
Q4
$2.28M Buy
51,820
+41,070
+382% +$1.78M 0.01% 808
2015
Q3
$513K Hold
10,750
﹤0.01% 1203
2015
Q2
$626K Buy
10,750
+500
+5% +$27K ﹤0.01% 997
2015
Q1
$518K Buy
10,250
+300
+3% +$14.7K ﹤0.01% 1096
2014
Q4
$447K Buy
9,950
+50
+0.5% +$2.1K ﹤0.01% 1165
2014
Q3
$365K Sell
9,900
-50
-0.5% -$1.98K ﹤0.01% 1257
2014
Q2
$439K Hold
9,950
﹤0.01% 1194
2014
Q1
$432K Sell
9,950
-100
-1% -$4.46K ﹤0.01% 1029
2013
Q4
$427K Hold
10,050
﹤0.01% 1056
2013
Q3
$341K Sell
10,050
-100
-1% -$3.26K ﹤0.01% 1141
2013
Q2
$317 Buy
+10,150
New +$329K ﹤0.01% 1163

Other funds holding CNMD

Thrivent Financial for Lutherans's CNMD Position: Q1 2026 in Review

Thrivent Financial for Lutherans reduced its CONMED (CNMD) stake by 2.9% in Q1 2026, selling an estimated $24.8K and leaving 20,671 shares worth $731K. The position accounts for ﹤0.01% of the portfolio, ranked #2057.

Thrivent Financial for Lutherans first reported a position in CNMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.05M in Q2 2023. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Thrivent Financial for Lutherans held 20,671 shares of CONMED worth $731K as of Q1 2026.
  • Thrivent Financial for Lutherans sold 609 CONMED shares in Q1 2026, an estimated $24.8K.
  • CONMED made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #2057 holding.
  • Thrivent Financial for Lutherans first reported a position in CONMED in Q2 2013 and has held it in 52 quarters since.
  • Thrivent Financial for Lutherans's CONMED position peaked at $4.05M in Q2 2023.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.